Partners
 |
Consorci Institut d’Investigacions Biomèdiques August Pi |
Spain |
 |
Belgium | |
 |
Fundació Privada Institut de Recerca de La Sida-Caixa (IRSICAIXA) | Spain |
 |
Aarhus University Hospital Skejby, Denmark Institute of Clinical Medicine, Aarhus University (AARHUS) | Denmark |
 |
Vrije Universiteit Brussel (VUB) | Belgium |
| Laboratory of Molecular Immunology, The Rockefeller University (LMI) | US | |
 |
Centro Nacional de Biotecnología, CSIC (CNB) | Spain |
 |
Faculty of Health Sciences, Simon Fraser University, Burnaby, British Columbia Centre for Excellence in HIV/AIDS (SFU) | Canada |
 |
European AIDS Treatment Group (EATG) | Germany |
 |
Facultad de Ciencias Económicas y Empresariales. Universidad Complutense de Madrid (UCM) | Spain |
 |
ECRIN (European Clinical Research |
France |
 |
Asphalion, S.L. (ASPHALION) | Spain |
 |
Assistance Publique Hôpitaux de Paris (APHP) | France |
 |
Zabala Innovation Consulting, S.A (ZABALA) | Spain |
 |
Aelix therapeutics SL | Spain |
Community representation
The HIVACAR project is developed with the contribution of representatives of the community of people living with HIV in Europe. The European AIDS Treatment Group (EATG) is a partner of the HIVACAR consortium and is responsible for: assessing, from the participants’...
HIVACAR aims to provide a new therapeutic alternative
Currently, over 36 million people worldwide are infected with HIV, most of them living in developing countries1. In 2014, 1.2 million people died of AIDS-related illnesses…